Laurent Bertoletti
@LaurentBertole1
Followers
2K
Following
37K
Media
622
Statuses
9K
chest physician fighting Vascular Diseases in @MedvascC at @ChuSaintEtienne @Univ_St_Etienne @INNOVTE1. Addict of #ASSE. Tweet#advise. Follow#endorsement
Saint-Etienne, France
Joined February 2018
❓ Do anticoagulants really improve survival in pulmonary arterial hypertension (#PAH)? Our study does shows that routine anticoagulation does not confer an overall survival benefit (HR: 0.997; 95% CI: 0.84-1.18). The discussion is open! 👇
1
9
16
❓ Do anticoagulants really improve survival in pulmonary arterial hypertension (#PAH)? Our study does shows that routine anticoagulation does not confer an overall survival benefit (HR: 0.997; 95% CI: 0.84-1.18). The discussion is open! 👇
1
9
16
What is the interest of MRI in patients with a suspected PE? @SanchezOlivie11 presenting the results of the multicenter #IRMEP2 trial, a project from the @INNOVTE1 network 🎉 #ers2025
@ErsPvd
0
0
2
Association Between Anticoagulant Therapy and Survival in Pulmonary Arterial Hypertension: A Registry Report and Updated Meta-Analysis | JACC
jacc.org
0
0
1
Thanks to all the patients and research teams for their contributions! #PAH #anticoagulation #cardiology and particularly to coauthors and editorial team from @JACCJournals for your help @MedvascC
@RespiFIL @pulmotension @Montanidavid @SouadBzh @AthenaisBoucly @AnticoagForum
2
0
2
🔚Overall, anticoagulation does not provide a measurable survival benefit. In the absence of randomized trials and given the risk of bleeding, this strategy should be reserved for carefully selected patients.
1
0
1
We then performed a meta‑analysis of contemporary national registry studies. The results confirm no significant reduction in mortality with anticoagulants (HR 0.98; 95% CI 0.78–1.23), regardless of PAH subgroup.
1
0
1
🔎We analyzed 1,597 incident patients diagnosed with PAH between 2009 and 2020, each with at least 3 years of follow-up. After propensity‑score matching, no survival benefit was found (HR 0.997; 95% CI 0.84–1.18), even in any PAH subtype.
1
0
1
❔Why this study? The use of anticoagulants in PAH remains controversial, with prior evidence limited to observational data and often contradictory We examined the French PAH Registry, supported by robust methodology and biostatistics experts 👋
1
1
0
Help EXPERT-PE mapping how Pulmonary Embolism Response Teams (PERT) work in Europe! If your hospital manages acute severe PE with a multidisciplinary team (formal PERT or not), please take 15–20 min to complete this urvey. 👉
docs.google.com
Mapping the real-world implementation, structure, activity, and challenges of Pulmonary Embolism Response Teams (PERT) across Europe. THE CONTENT OF THIS SURVEY WILL BE TREATED CONFIDENTIALLY This...
3
9
17
Help shape care for pregnant patients with sickle cell disease.👇 https://t.co/SehPFBD36v
#SickleCell #MaternalHealth #Hydroxyurea #MedTwitter
@ASH_hematology
We invite healthcare professionals who manage pregnant patients with sickle cell disease to share their insights and experiences in our survey. We are particularly interested in hearing various perspectives, especially regarding the potential use of hydroxyurea.’ @pshangaris
0
5
16
Peuple Stéphanois, On prépare une collecte de fournitures scolaires pour le premier match à domicile. N’hésitez pas à apporter tout ce qui pourrait aider les Mâtrus à faire une bonne rentrée ! GA92 UNIS FIERS ET SOLIDAIRES
0
189
461
QUE LE SPECTACLE COMMENCE ! Suivez la Cérémonie d'ouverture des Jeux Olympiques de Paris 2024 en direct : https://t.co/qsB1Tdiqg5
#ceremoniedouverture #paris2024
196
2K
7K
🫁 Derivation and Validation of a COPD-specific Pulmonary Embolism Diagnostic Strategy ⬇️ 📌 Mai et al. derived a #COPD-specific algorithm 📌 Diagnostic failure rate: 0.9%; 53.4% patients would need imaging to rule out #PE 👉 https://t.co/4D3MJ9fx0c
#VTE #Thrombosis
0
9
14
Assessing Tilt and Retrieval Challenges with Inferior Vena Cava Filters: Comparison of Original and Anti-Tilting Models of the ALN Filter - Journal of Vascular and Interventional Radiology https://t.co/vtIEimNKwp
@MedvascC
0
3
8
Rétrogradation de l'OL en L2 - La LFP autorise Saint-Étienne à ajouter une seconde étoile sur son maillot
5
118
1K
SFPT 2025 annual meeting abstracts now available: https://t.co/EcTAd6f5cg
#SFPT #Wiley #fundamental #clinical #pharmacology #drug #therapeutic #pharmacogenetic #toxicology #pharmacoepidemiology #medication #cardiovascular #renal #disease #methodology #neurology #oncology
onlinelibrary.wiley.com
Click on the title to browse this issue
0
2
5